Literature DB >> 15668828

Coronary artery spasm induced by 5-fluorouracil.

P Alter1, M Herzum, J R Schaefer, B Maisch.   

Abstract

The frequently used chemotherapeutic drug 5-fluorouracil (5-FU) is known to cause angina pectoris and arrhythmias; myocardial infarction and sudden cardiac death could occur. Potential reasons for these phenomena range from toxic/metabolic disturbances to coronary artery spasms. This report shows angiographically proven spasmophilia of the coronary arteries and contributes to the understanding of angina pectoris occurring during treatment with 5-FU. Thus, verapamil type calcium antagonists as well as nitrates should be administered primarily in patients with coronary artery disease and in all patients who had been symptomatic during 5-FU administration in order to prevent further episodes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668828     DOI: 10.1007/s00392-005-0159-8

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  22 in total

Review 1.  Calcium-antagonist drugs.

Authors:  D R Abernethy; J B Schwartz
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

2.  Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study.

Authors:  S Rezkalla; R A Kloner; J Ensley; M al-Sarraf; S Revels; A Olivenstein; S Bhasin; S Kerpel-Fronious; Z G Turi
Journal:  J Clin Oncol       Date:  1989-04       Impact factor: 44.544

3.  Ischemic chest pain after 5-fluorouracil therapy for cancer.

Authors:  W P Baker; P Dainer; W M Lester; A M Marty; T P Blair
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

4.  The anti-neoplastic drug 5-fluorouracil produces echinocytosis and affects blood rheology.

Authors:  G M Baerlocher; J H Beer; G R Owen; H J Meiselman; W H Reinhart
Journal:  Br J Haematol       Date:  1997-11       Impact factor: 6.998

5.  Letter: 5-Fluorouracil and angina.

Authors:  R G Dent; I McColl
Journal:  Lancet       Date:  1975-02-08       Impact factor: 79.321

6.  The clinical syndrome of 5-fluorouracil cardiotoxicity.

Authors:  J F Ensley; B Patel; R Kloner; J A Kish; J Wynne; M al-Sarraf
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

Review 7.  Cardiotoxicity of chemotherapy.

Authors:  M de Forni; J P Armand
Journal:  Curr Opin Oncol       Date:  1994-07       Impact factor: 3.645

Review 8.  Fluorouracil cardiotoxicity.

Authors:  A J Anand
Journal:  Ann Pharmacother       Date:  1994-03       Impact factor: 3.154

9.  In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle.

Authors:  M Mosseri; H J Fingert; L Varticovski; S Chokshi; J M Isner
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

Review 10.  The syndrome of 5-fluorouracil cardiotoxicity. An elusive cardiopathy.

Authors:  N C Robben; A W Pippas; J O Moore
Journal:  Cancer       Date:  1993-01-15       Impact factor: 6.860

View more
  5 in total

1.  [Angina pectoris and ST-elevation after chemotherapy with 5-fluorouracil].

Authors:  S Spencker; A Schmittel; D Westermann; A Marek; H P Schultheiss; B Witzenbichler
Journal:  Internist (Berl)       Date:  2007-01       Impact factor: 0.743

2.  Coronary artery spasm of the native right coronary artery during off-pump coronary surgery of the left coronary artery system.

Authors:  Torsten Bossert; Hartmuth Bruno Bittner; Jan Fritz Gummert; Friedrich Wilhelm Mohr
Journal:  Clin Res Cardiol       Date:  2006-01-16       Impact factor: 5.460

Review 3.  Cancer and Coronary Artery Disease: Common Associations, Diagnosis and Management Challenges.

Authors:  Debashish Das; Alex Asher; Arjun K Ghosh
Journal:  Curr Treat Options Oncol       Date:  2019-05-06

4.  5-Fluorouracil-induced acute reversible heart failure not explained by coronary spasms, myocarditis or takotsubo: lessons from MRI.

Authors:  Yama Fakhri; Morten Dalsgaard; Dorte Nielsen; Per Lav Madsen
Journal:  BMJ Case Rep       Date:  2016-06-01

Review 5.  The Role of Vasospasm and Microcirculatory Dysfunction in Fluoropyrimidine-Induced Ischemic Heart Disease.

Authors:  Natalia Fabin; Maria Bergami; Edina Cenko; Raffaele Bugiardini; Olivia Manfrini
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.